Stocks to watch: Medtecs, SMI Vantage, QT Vascular

THE following companies saw new developments that may affect trading of their securities on Thursday (Nov 18):

Medtecs International: 546 The medical products supplier's third-quarter financial performance is not expected to be as strong as that for the first 6 months of the year, but the group will remain profitable, the Catalist-listed company said on Wednesday (Nov 17). Separately, its board has approved the appointment of James Lin as chief financial officer. Its shares closed S$0.01 or 3 per cent lower at S$0.325 on Nov 17, before the announcements.

SMI Vantage: Y45 The mainboard-listed investment and management company said on Wednesday (Nov 17) that it has signed a memorandum of understanding with Nasdaq-listed substantial shareholder The9 to develop a non-fungible token publishing business. Shares of SMI Vantage closed S$0.001 or 1.6 per cent higher at S$0.065 on Nov 17, before the announcement.

QT Vascular: 5I0 The Catalist-listed medtech company on Wednesday (Nov 17) announced that it will hold an extraordinary general meeting (EGM) on Dec 2 to seek shareholders' approval for the appointment of 5 new directors. This comes a day after the company said it had received a notice of intention from Mission Well Limited and Tansri Saridju Benui, who together hold more than 10 per cent of the company, to call for an EGM to remove 4 current board members. The company had called for a trading halt on Tuesday (Nov 16). Shares of QT Vascular last traded at S$0.01.

Trading halt:

GSS Energy 41F has called for a trading halt on Thursday (Nov 18) morning, pending the release of an announcement. Shares last closed flat on Wednesday (Nov 17) at S$0.077.